Stryker Corporation vs Zoetis Inc — how do they compare? Stryker Corporation trades at $319.04 (market cap $122.35B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Stryker Corporation is far larger — about 3.8× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| SYK | ZTS | |
|---|---|---|
Market Cap | $122.35B | $31.95B |
Sector | Technology | Health |
52-Week High | $403.53 | $156.76 |
52-Week Low | $282.58 | $71.91 |
Enterprise Value | $134.10B | $39.24B |
Dividend Yield | 1% | 2.78% |
Trailing returns across standard periods
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →